Issued in response to changes in the FDA's emergency use authorizations, the FAQs reiterate requirements to conduct two tests, 48 hours apart, when using antigen point-of-care or at-home tests on symptomatic individuals who test negative.

The Quick Guide will be livestreamed on Jan. 19^th and provided on demand as well.

State is accepting comments until Jan. 6, 2023.